[Significance of prostate central gland/total gland volume ratio combined with PSA in the diagnosis of prostate cancer patients].

Guo, Z F; Lu, X W; Yang, F; Wu, J W; Wang, H; He, C

Guo, Z F; Lu, X W; Yang, F; Wu, J W; Wang, H; He, C.

Afiliación

Guo ZF; Department of Urology, Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Shanghai 201199, China.
Lu XW; Department of Urology, Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Shanghai 201199, China.
Yang F; Department of Urology, Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Shanghai 201199, China.
Wu JW; Department of Urology, Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Shanghai 201199, China.
Wang H; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
He C; Department of Urology, Minhang Branch, Zhongshan Hospital, Fudan University/Institute of Fudan-Minhang Academic Health System, Shanghai 201199, China.

Zhonghua Yi Xue Za Zhi ; 99(36): 2836-2839, 2019 Sep 24.

Article en Zh | MEDLINE | ID: mdl-31550812

Asunto(s)

Neoplasias de la Próstata; Humanos; Masculino; Antígeno Prostático Específico; Neoplasias de la Próstata/diagnóstico; Curva ROC; Estudios Retrospectivos; Sensibilidad y Especificidad

Palabras clave

Benign prostatic hyperplasia; Central gland; PSA; Prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google